Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

PAR-22-075: NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)

Closed Closed January 7, 2025 Opportunity PAR-22-075

This grant is closed. A newer notice from the same program is open now: NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) (PAR-25-251). Status: Due dates in the notice, expires January 7, 2028. It is in our archive of National Institutes of Health notices from 2022.

National Institutes of Health offered grants to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on January 7, 2025.

From the official notice on Grants.gov, last changed January 20, 2022. Checked November 7, 2026.

About this NIH notice

Projects funded under PAR-22-075 were run by National Institute of Allergy and Infectious Diseases (NIAID, 31 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read PAR-22-075 in the NIH Guide.

Other notices with this title

National Institutes of Health has posted this title under other numbers: earlier or later rounds, or the same competition for another area. Each has its own dates and may change its rules.

NoticePostedDeadlineStatus
PAR-25-251December 3, 2024Due dates in the notice, expires January 7, 2028Open

Key dates

PostedJanuary 20, 2022
DeadlineJanuary 7, 2025
Archived by Grants.govFebruary 12, 2025

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The purpose of the NIAID Career Transition Award (CTA) program is to assist postdoctoral fellows' transition to positions of assistant professor or equivalent and initiate a successful biomedical career as an independent research scientist. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by another investigator.

Category: Health.

Funded under PAR-22-075 so far

NIH funded 31 projects under PAR-22-075 in fiscal 2024 to 2026, at 27 institutions. The median yearly award was $158,433.

Most projects: University of Pittsburgh at Pittsburgh (Pennsylvania), 2, Northwestern University (Illinois), 2, Clemson University (South Carolina), 2, Johns Hopkins University (Maryland), 2, Univ of North Carolina Chapel Hill (North Carolina), 1.

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Allergy and Infectious Diseases Research grants before

From fiscal 2021 to 2025, Allergy and Infectious Diseases Research (93.855) awarded $22 billion across 13,282 grant awards, an average of $1.6 million per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Fred Hutchinson Cancer CenterWashington85$938 million
Duke UniversityNorth Carolina230$781 million
University of California, Los AngelesCalifornia138$745 million
The Johns Hopkins UniversityMaryland321$668 million
Emory UniversityGeorgia282$650 million

Top states: California ($3.4 billion), Massachusetts ($2.1 billion), Washington ($1.9 billion), New York ($1.8 billion), North Carolina ($1.5 billion).

Applying now

This notice no longer takes applications. Apply under the newer notice, PAR-25-251, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is PAR-22-075 still open?

No. It closed on January 7, 2025. A newer notice is open: PAR-25-251, due dates in the notice, expires January 7, 2028.

Who can apply for NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)?

Closed January 7, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

Who has been funded under PAR-22-075?

NIH RePORTER lists 31 projects funded under PAR-22-075 in fiscal 2024 to 2026, at 27 institutions. The most were at University of Pittsburgh at Pittsburgh, Northwestern University, Clemson University.

Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.

Similar open grants